Erythrocyte-mediated microinjection was used to introduce [35S] Microinjected 125I-labelled bovine serum albumin is rapidly degraded by a cytosolic mechanism at the same rate in the absence or presence of reticulocyte lysate. The data do not support the notion that the observed lack of degradation of microinjected [35S]polypeptides translated in vitro is due to the presence of proteolytic inhibitors in reticulocyte lysates which can inhibit the degradation of microinjected or cellular proteins.
INTRODUCTION
The mechanisms of intracellular protein degradation, including the molecular criteria by which a protein is targetted to a degradative system, are not understood. Protein degradation has been demonstrated to occur both lysosomally and non-lysosomally (Dean, 1975; Amenta & Brocher, 1981; Hendil, 1981; Rote & Rechsteiner, 1983; McElligott & Dice, 1983; Doherty & Mayer, 1985a,b) . In contrast with protein synthesis, it is very difficult at present to define the intracellular site of degradation of a single protein or group of proteins.
In the last few years techniques such as erythrocytemediated microinjection (Schlegel & Rechsteiner, 1975) , needle microinjection (Graessmann & Graessmann, 1971 ) and scrape-loading (McNeil et al., 1984) have been developed which enable specific radiolabelled proteins to be introduced into unlabelled target tissue-culture cells so that their degradation may be studied. Several reports describe the degradation of proteins microinjected into cells (Hendil, 1980; Dice, 1982 , Hough & Rechsteiner, 1984 Katznelson & Kulka, 1985; Doherty & Mayer, 1985a) , but mature processed proteins have been routinely used in these studies. We have therefore studied the intracellular fate of microinjected [35S] polypeptides translated in vitro (consisting of precursor polypeptides lacking co-and post-translational modifications). Differences in the intracellular processing of microinjected precursor polypeptides, compared with microinjected mature proteins, are valuable in order to define the molecular criteria for targetting proteins into the intracellular degradative systems.
MATERIALS AND METHODS Materials
3T3-LI pre-adipocytes were obtained from the American Type Culture Collection (Rockville, MD, U.S.A.). Dulbecco's modified Eagle's medium was supplied by Gibco Bio-Cult (Paisley, Scotland, U.K.) and 90 mm-diam. plastic tissue-culture dishes were from Nunc (Kamstrup, Denmark). Newborn-calf serum was supplied by Imperial Laboratories (Salisbury, Wilts., U.K.). All radioisotopes were from Amersham International (Amersham, Bucks., U.K.), and penicillin G, streptomycin, trypsin, oligo(dT)-cellulose and protein Mr standards were from Sigma Chemical Co. (Poole, Dorset, U.K.). Fisofluor was obtained from Fisons (Loughborough, Leics., U.K.) and pre-packed Sephadex G-25 columns were from Pharmacia Fine Chemicals (Hounslow, Middx., U.K.). Tissue culture 3T3-L1 cells were cultured as described by Doherty & Mayer (1985a) . Radiolabelling of proteins 3T3-L1 monolayers were radiolabelled metabolically by culture with [35S]methionine (1 t,Ci/ml of culture medium). Cells were then washed, removed for subcultivation by incubation with trypsin and resuspended in Dulbecco's modified Eagle's medium plus 10% (v/v) newborn-calf serum, antibiotics and 10 mM-methionine. Haemoglobin in reticulocyte lysates was reductively methylated with NaB3H4 by the method of Tack et al. (1980) . Bovine serum albumin was radioiodinated with Na125I by the method of Hunter & Greenwood (1962) .
mRNA isolation
Liver mRNA was prepared by the method of Aviv & Leder (1972) .
Translation of radiolabelled polypeptides in vitro
The mRNA-dependent rabbit reticulocyte lysate was prepared by the method of Pelham & Jackson (1976) . Radiolabelled polypeptides were synthesized in the mRNA-dependent reticulocyte lysate in the presence of [35S]methionine by the method of Pelham & Jackson (1976) as modified by Andus et al. (1983) .
Vol. 241
Preparation of protein samples for microinjection Reticulocyte lysates (usually ten 50 ,u1 translation mixtures) containing [35S]polypeptides were pooled and layered on to 1 ml of 1.2 M-sucrose (adjusted to pH 7.4 with NaHCO3) in a 2 ml insert tube of a 10 x 10 ml MSE centrifuge rotor. Ribosomes in the reticulocyte lysate were sedimented by centrifugation at 180000 av for 45 min. The red supernatant on the sucrose cushion was removed and applied to a Sephadex G-25 column (1 cm x 10 cm) pre-equilibrated with 10 mM-NaH2PO4 buffer, pH 7.4, containing 10 mM-methionine. The red void-volume fraction was collected. This procedure removes > 98 % of the free [35S]methionine present in the reticulocyte lysate. The lysate was concentrated to the desired volume for loading into erythrocytes by ultrafiltration in an Amicon (Stonehouse, Gloucs., U.K.) stirred cell with a 10000-Da filter.
Microinjection
Radiolabelled polypeptides were loaded into human erythrocytes and microinjected into 3T3--L1 cells by using Sendai virus by the method of Schlegel & Rechsteiner (1975) as modified by Doherty & Mayer (1985a) . After fusion at 37°C, cells were pelleted at 500 g for 2 min, suspended in 2 ml of 0.83% (w/v) NH4C1 (at 4°C), to lyse red blood cells, layered on to 8 ml of a 1:1 (v/v) mixture of newborn-calf serum and 0.83% NH4Cl in a pointed sterile tube, and centrifuged at 500 g for 2 min. The washing procedure was repeated once, and the cells were then resuspended in growth medium at 37°C for immediate use.
Measurement of protein degradation
Protein degradation was measured either by the method described by Doherty & Mayer (1985a) or from the rate of loss of cell-associated trichloroacetic acid (final concn. 10%, w/v)-insoluble radioactivity.
Enzyme activities
The enzyme assays carried out on each detergent/salt fraction were lactate dehydrogenase (EC 1.1.1.27) (Johnson, 1960) , acid phosphatase (EC 3.1.3.2) (de Duve et al., 1955) and succinate dehydrogenase (EC 1.3.99.1) (Pennington, 1961 Microinjected 135Sjpolypeptides translated in vitro are stable in 3T3-L1 cells for at least 2 h after microinjection
Microinjected polypeptides translated in vitro may be degraded very rapidly in 3T3-L1 cells, e.g. by mechanisms which degrade amino-acid-analogue-containing proteins (Goldberg & Dice, 1974; Knowles & Ballard, 1976; Wharton & Hipkiss, 1984; Ciechanover et al., 1984) . Fig  4 shows the cell-associated trichloroacetic acid-insoluble radioactivity in 3T3-L1 cells in suspension at 37 'C over a 2 h period. In this experiment microinjected cells were resuspended after washing at 4 'C (see the Materials and methods section) in warm (37°C) medium and the cell suspension was used immediately. Endogenous 35S-radiolabelled proteins (A) and endogenous proteins radiolabelled (cf. methionine (@) undergo rapid degradation in 3T3-LI cells. In the presence of 10 mM-methionine (0) (Jackson, 1973 shown by polyacrylamide-gel electrophoresis under denaturing conditions; results not shown). Fig. 7 shows that the loss of cell-associated trichloroacetic acidinsoluble radiolabel shows complex kinetics. Transformation of the data to ln radioactivity (d.p.m.) against time (Fig. 7, insert) shows that, initially, microinjected [3H]haemoglobin is degraded with a half-life of approx. 173 h. As cell density increases, the half-life decreases to 65 h. The increase in rate occurs after approx. 45 h, at which time the 3T3-L1 cells are over 50% confluent (results not shown). A more complex interpretation of Fig. 7 (insert) (Fig. 9 ). NH4C1 (10 mM) has no effect on the degradation of microinjected [3H]haemoglobin or on its subcellular location in the cytosol (results not shown).
Micrc-injected 1251-labelled bovine serum albumin is degraded at similar rates in the presence and absence of co-microinjected reticulocyte lysate Bovine serum albumin 125I-labelled was microinjected into 3T3-L1 cells in the presence and absence of reticulocyte lysate to observe any differences in albumin degradation. Microinjected cells were seeded into culture dishes at 104 cells/cm2. Fig. 10 shows the degradation of microinjected 251I-labelled bovine serum albumin in the presence (0) and absence (0) of co-microinjected reticulocyte lysate. The calculated half-lives of 181 and 18 h respectively are in good agreement with the half-life of 21 h reported by Doherty & Mayer (1985b) . The degradation of microinjected 1251I-labelled bovine serum albumin is insensitive to 10 mM-NH4Cl (Rote & Rechsteiner, 1983; Doherty & Mayer, 1985b) . The microinjected 1251-labelled bovine serum albumin (like haemoglobin) is predominantly (> 80%) in the digitoninextractable cytosol (Fig. 9) (Doherty & Mayer, 1985a erythrocytes, before fusion with 3T3-Ll cells (Fig. 2) (1985) . The observation that there is little degradation of loaded [35S]polypeptides in erythrocytes (Fig. 2) is very important because of the demonstration of several degradative systems in reticulocyte lysates and erythrocytes. Hershko et al. (1978) (Fig. 4) , despite the existence of characterized systems for the degradation of amino-acid-analogue-containing abnormal proteins (Goldberg & Dice, 1974; Knowles & Ballard, 1976; Wharton & Hipkiss, 1984) which may be associated with a ubiquitin-dependent pathway (Fig. 6 ) occurs in both growing and confluent 3T3-L1 cells over a 70 h time period. This is in marked contrast with all other microinjected mature proteins; see, e.g., Zavortinck et al. (1979 ), Hendil (1980 , Rote & Rechsteiner (1983) and Doherty & Mayer (1985a) .
Microinjection of reticulocyte lysate into growing 3T3-L1 cells caused little alteration to the rate of endogenous-protein degradation (Fig. 6) . It has previously been demonstrated that erythrocyte microinjected homologous cytosol mixtures (Doherty & Mayer, 1985a) and single proteins (Hendil, 1980; Backer et al., 1983; McElligott & Dice, 1984) do not alter the rate of endogenous protein degradation.
It is possible that the lysate contains inhibitors of some specific proteolytic mechanism required for degradation of proteins in reticulocyte lysate. This possibility was investigated for lysate haemoglobin after reductive methylation with NaB3H4. The results (Fig. 7) (0) (Hendil, 1981; Amenta & Brocher, 1981; Mayer & Doherty, 1986) . The erythrocyte is an unlikely source of inhibitors, since many proteins have been microinjected into cells by using erythrocytes and degraded with simple kinetics, e.g. bovine serum albumin ( Fig. 10 ; Rote & Rechsteiner, 1983; Doherty & Mayer, 1985b) , RNAase (Backer et al., 1983; McElligott et al., 1985) and several other proteins (Rogers & Rechsteiner, 1985) . (Slot et al., 1986) . These complementary data support the digitonin-extractability of cytosol from cells (Mackall et al., 1979; Earl et al., 1987b Stacey & Allfrey (1977) and Hendil (1980) , who were unable to demonstrate any association of microinjected haemoglobin with lysosomes. The complex degradation kinetics for haemoglobin are therefore not due to enhanced autophagic degradation as cells approach confluency.
Degradation of microinjected 125I-labelled bovine serum albumin is also insensitive to NH4Cl (Rote & Rechsteiner, 1983; Doherty & Mayer, 1985b) . Over 80% of microinjected 125I-labelled bovine serum albumin is in the digitonin-extractable cytosol (results not shown), and albumin remains in the cytosol throughout degradation. This implies catabolism by a cytosolic degradative system, though not necessarily the same cytosolic system that degrades microinjected [3H]haemoglobin (Fig. 7) , since 1251-labelled bovine serum albumin is degraded with different kinetics (Fig. 10) . Complex degradation kinetics for injected proteins similar to those described here have been noted previously (Rechsteiner et al., 1984) .
Overall, the experiments reported here provide no data to support the idea that reticulocyte lysate contains proteolytic inhibitors capable of preventing the degradation of microinjected [35S]polypeptides translated in vitro.
[35S]Polypeptides synthesized in vitro translated from liver mRNA are essentially unprocessed, e.g. retaining leader sequences and lacking prosthetic groups (Clemens, 1984) . Microinjected polypeptides in such a protein mixture translated in vitro may therefore be unable to gain access to functional sites, and retain atypical conformations in target cells. Secretory-protein mRNA constitutes approx. 28% of total liver mRNA (Scornik & Botbol, 1976) . Secretory proteins translated in vitro will contain cleavable leader sequences and may be miscompartmented in the cell after microinjection. Therefore most microinjected [35S]polypeptides translated in vitro may have structures and conformations which render them refractory to normal intracellular degradative processes.
Note added in proof (received 14 November 1986) Bachmair et al. (1986) have provided evidence that the nature of the N-terminal amino acids of 8-galactosidases expressed from transfected mutant genes in yeast determines enzyme degradation rate. The 'N-end rule' of Bachmair et al. (1986) is supported and extended by the observations reported here, which suggest that N-terminal sequences may control protein degradation even to the extent of rendering proteins refractory to degradative mechanisms: the question remains as to how this is achieved.
